| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Mumps Virus Antibody (IgM)
Test CodeMUMMA
Alias/See Also
LAB161
CPT Codes
<p>86735</p>
Preferred Specimen
Specimen Type: Serum
Collection Container/Type
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic set
Specimen Volume: 1 mL
Minimum Volume
0.2 mL
Transport Container
Plastic screw-cap vial
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 7 days
Refrigerated: 14 days
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Gross hemolysis • Gross lipemia
Methodology
Immunofluorescence Assay (IFA)
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Tues-Sat; Report available: 1-3 days
Report Available
1-3 days
Reference Range
Mumps Virus Antibody (IgM)
The presence of IgM antibody to mumps typically indicates recent or current mumps infection; however, false positive results may occur due to antibody cross reactivity to parainfluenza virus.
| Titer | Interpretation |
| <1:20 | Antibody not detected |
| ≥1:20 | Antibody detected |
Clinical Significance
Used in the diagnosis of acute mumps infection.
Performing Laboratory
Quest Diagnostics Nichols Institute 14225 Newbrook Drive Chantilly, VA 20153
Last Updated: February 17, 2023